Four years ago, Dendreon (DNDN) was the darling of the biotech sector with a promising cancer vaccine awaiting FDA approval and a stock price sitting above $50 a share.
Today, Dendreon sits just above $2 and CEO John Johnson is out the door after resigning for what the company calls ��ersonal reasons.��Cantor Fitzgerald analyst Maria Goldstein asks if this is �� step down or a step forward��for the financially troubled biotech firm.
She writes:
On the one hand, Johnson’s departure was unexpected. Yet on the other hand, the company is at a critical juncture with modest cash left, a large debt overhang and struggling commercial operations that has yet to fully gain buy-in from the clinical community that it serves. With major layoffs already occurring, and losses of the CFO and the head of commercial operations in the past year, perhaps Johnson’s departure is not so unexpected. Nonetheless, we think the only question really to be answered is whether Mr. Johnson’s exit will force a meaningful change in the sales trend for Provenge.
Top 5 Performing Stocks To Own Right Now: Medley Capital Corporation (MCC)
Medley Capital Corporation is a business development company. The fund seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It targets private debt transactions ranging in size from $10 million to $50 million to borrowers principally located in North America. It structures its investments as first lien senior secured loans, second lien senior secured loans, senior secured notes, senior subordinated notes, unitranche loans, and seeks warrants or other equity participation. The fund may take a board seat on its investee companies and exits its investments between three years and seven years.
Advisors' Opinion:- [By Nathan Slaughter]
All of this is to say that while I strive to hunt down and recommend attractive securities with double-digit yields -- and own a few, like Medley Capital Corp. (NYSE: MCC) -- they are the exception in this environment, not the rule.
Top 10 Promising Stocks For 2015: CVS Corporation(CVS)
CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
kurhan/Shutterstock The maker of a line of diet supplements sold at the nation's largest pharmacies with the false promise that the pills would magically make users slender (they didn't) was banned -- at least, for now -- from selling weight loss products under a just-finalized agreement, the Federal Trade Commission said on Friday. HealthyLife Sciences and its principal sold Healthe Trim supplements with the claim you could "get high school skinny." Apparently, it only worked as advertised if its users had never gained weight after graduation. John Matthew Dwyer III (aka Matthew Dyer), the co-founder of the Atlanta-based company, agreed to stay out of the weight-loss industry under the terms of the settlement of deceptive advertising charges. Dwyer claimed the pills had ingredients that combined to burn fat, speed up the metabolism and suppress appetite. No Penalty, No Restitution The FTC said the company took in about $76 million between 2009 and 2013. Healthe Trim supplements were sold at CVS (CVS), Walgreens (WAG) and at GNC (GNC) stores. It cost consumers who bought into the spiel $50 to $65 for a month's supply, the FTC said. The key to the sales were customer testimonials featuring claims that, for example, using the pills helped one user to drop 54 pounds and go from a size 12 dress to a size 2. "Losing weight is rarely easy, and it would be a miracle if a pill made it so," Jessica Rich, director of the FTC's Bureau of Consumer Protection, said in a statement. "Consumers should be skeptical when a product like this one claims to make weight loss easy." The company itself (if it continues to operate without Dwyer) is barred from making a host of what the FTC describes as "scientifically infeasible" claims about its supplements. And it can no longer make any weight-loss-related claims at all about them until it has in hand two legitimate, scientifically rigorous human clinical-trial studies to support its statements. Unlike many settlements of this
- [By Brad Thomas]
Like many of the other Triple-Net REITs, Agree operates its investment platform with a variety of free-standing net lease tenants including many household names such as Walgreens (WAG), CVS (CVS), Staples, Chase Bank, AutoZone (AZO), Advance Auto Parts (AAP), Lowe's (LOW), McDonald's (MCD), Family Dollar (FDO), Harris Teeter, Dollar General (DG), and Wawa. As shown below, Agree has a majority (88%) of nationally-recognized tenants, including many investment grade retailers (62.6%).
- [By WALLSTCHEATSHEET]
CVS Caremark provides healthcare and general products and services to consumers across the nation. The company named long-serving executive Helena Foulkes to replace Mark Cosby as president of the company’s pharmacy business. The stock has been rising higher and is now trading near all time high prices. Over the last four quarters, earnings and revenue figures have been increasing leaving investors pleased about CVS Caremark�� earnings announcements. Relative to its peers and sector, CVS Caremark has been an average year-to-date performer. Look for CVS Caremark to OUTPERFORM.
Top 10 Promising Stocks For 2015: Commercial Bancshares Inc (CMOH)
Commercial Bancshares, Inc. is a financial holding company. The Company�� banking subsidiary, The Commercial Savings Bank (the Bank), is engaged in the business of commercial and retail banking, with operations conducted through its main office and branches located in Upper Sandusky, Ohio and neighboring communities in Wyandot, Marion and Hancock counties. The Bank provides customary retail and commercial banking services to its customers, including acceptance of deposits for demand, savings and time accounts, individual retirement accounts (IRAs) and servicing of such accounts; commercial, consumer and real estate lending, including installment loans, and safe deposit and night depository facilities. Commercial Financial and Insurance Agency, LTD is its wholly owned subsidiary. The Bank also owns a 49.9% interest in Beck Title Agency, Ltd.
Lending Activities
The Bank grants residential, installment and commercial loans to customers located primarily in the Ohio counties of Wyandot, Marion and Hancock and the surrounding area. Commercial loans are primarily variable rate and include operating lines of credit and term loans made to small businesses primarily based on the ability to repay the loan from the cash flow of the business. Commercial real estate loans are primarily secured by borrower-occupied business real estate, and are dependent on the ability of the related business to generate adequate cash flow to service the debt. Residential real estate loans are made with primarily variable rates and are secured by the borrower�� residence. As of December 31, 2011, approximately 75.5% of the Company�� loan and lease portfolio consisted of commercial, construction and commercial real estate loans.
Investment Activities
Securities are classified as available for sale. Securities available for sale are carried at fair value. The securities available for sale include obligations of the United Sates Government and federal agencies, obligations of ! state and political subdivisions, and mortgage-backed securities. As of December 31, 2011, total securities available for sale were approximately $24.5 million, which included approximately $4.06 million of obligations of the United Sates Government and federal agencies, approximately $14.3 million of obligations of state and political subdivisions, and approximately $6.4 million of mortgage-backed securities.
Sources of Funds
As of December 31, 2011, the Company had approximately $259.1 million of deposits, which included approximately $ 38.1 million of noninterest-bearing demand, approximately $103.7 million of interest-bearing demand, approximately $ 86.9 million of savings and approximately $ 30.2 million of time deposits $100,000 and greater. As of December 31, 2011 the Company had no borrowings with Federal Home Loan Banks (FHLB).
Advisors' Opinion:- [By Doug Hughes]
Commercial Bancshares (CMOH) operates as the holding company for The Commercial Savings Bank, with just over $300,000 in assets and $259,000 million in loans. This small, but very strong bank had 5% loan growth last year and net charge-offs of just 0.23%.
Top 10 Promising Stocks For 2015: IsoRay Inc (ISR)
IsoRay, Inc. (IsoRay), incorporated on June 15, 2004, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association (FDA) for treatment for all solid tumor applications using Cesium-131. Such applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer, and pancreatic cancer. The seed may be used in surface, interstitial and intracavity applications for tumors with known radio sensitivity. The Company has an existing distribution agreement with UralDial LLC (UralDial) that allows UralDial to distribute Proxcelan Cs-131 brachytherapy seeds in Russia. The Company, through UralDial, has regulatory approval to sell Cs-131 seeds in Russia.
IsoRay markets the Proxcelan Cesium-131 brachytherapy seed for the treatment of prostate cancer; lung cancer; ocular melanoma; head and neck cancers; colorectal cancer, brain cancer; and gynecological cancer. The Company focuses to market Cesium-131 for the treatment of other malignant disease, such as breast cancer, in the near future through the use of existing technologies that have received FDA-clearance. Cesium-131 is a radioactive isotope that can be produced by the neutron bombardment of Barium-130 (Ba-130). When placed into a nuclear reactor and exposed to a flux of neutrons, Ba-130 becomes Ba-131, the radioactive material that is the parent isotope of Cesium-131. The radioactive isotope Cesium-131 is normally produced by placing a quantity of stable non-radioactive barium (ideally barium enriched in isotope Ba-130) into the neutron flux of a nuclear reactor. The irradiation process converts a small fraction of this material into a radioactive form of barium (Ba-131). The Ba-131 decays by electron capture to the ! radioactive isotope of interest (Cesium-131).
As of June 30, 2011, IsoRay had agreements with several independent radiopharmacies to assay, preload, and sterilize loose seeds. During the fiscal year ended June 30, 2011, the Company loaded approximately 90% of Mick cartridges in the Company's own facility, which accounted for approximately 61% of seeds sold. Approximately 33% of seeds sold are strand configurations, including strands preloaded in needles and the remaining 6% of seeds are sold as loose seeds.
Advisors' Opinion:- [By Vanina Egea]
Strengthening portfolio and business stability is to be reinforced by the introduction of new products. Last December, Textron announced the successful first flight of the Scorpion Intelligence, Surveillance and Reconnaissance (ISR)/Strike aircraft. ��he Scorpion compares very favorably to more costly aircraft currently used for low-threat missions,��pilot Dan Hinson said. The new product is expected to accommodate the budget constraints and shifting mission requirements of the US Department of Defense. The same department has granted the firm an additional contract worth $22.5 million to "deprocess" Mobile Strike Force vehicles and train the Afghan Army.
Top 10 Promising Stocks For 2015: ManpowerGroup(MAN)
ManpowerGroup provides workforce solutions and services worldwide. The company offers permanent, temporary, and contract recruitment services; assessment and selection services; training and development services; outsourcing services; and workforce consulting services. It also provides professional resourcing and project-based workforce solutions in the information technology, finance, and engineering fields; talent and career management workforce solutions; and talent based outsourcing services, managed services, recruitment process outsourcing services, borderless talent solutions, and strategic workforce consulting services. The company was founded in 1948 and is headquartered in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Rich Duprey]
Investors have taken notice of the trend with shares of ManpowerGroup (NYSE: MAN ) rising 59% over the past year, Kelly Services (NASDAQ: KELYA ) up almost 46%, and Robert Half International (NYSE: RHI ) some 15% higher.
- [By idahansen]
The more I read about how companies are responding to Obamacare, the more bullish I become for stocks in the demand labor market such as Labor SMART (OTCBB: LTNC), Paychex (NASDAQ: PAYX), and ManpowerGroup (NYSE: MAN).
- [By Monica Gerson]
ManpowerGroup (NYSE: MAN) is expected to report its Q3 earnings at $1.08 per share on revenue of $5.08 billion.
Celanese (NYSE: CE) is estimated to report its Q3 earnings at $1.04 per share on revenue of $1.59 billion.
- [By Dan Burrows]
Staffing stocks like Manpower Group (MAN), Robert Half International (RHI) and Kelly Services (KELYA) have put up market-beating to market-crushing gains over the last year, boosted by accelerating strength in the job market.
Top 10 Promising Stocks For 2015: TriMas Corporation(TRS)
TriMas Corporation designs, manufactures, and distributes various products for commercial, industrial, and consumer markets worldwide. Its Packaging segment offers steel and plastic closure caps, drum enclosures, rings and levers, and specialty plastic closures, as well as dispensing systems, such as pumps and specialty sprayers to store, transport, process, and dispense various products for industrial, agricultural, food, beverage, personal care, pharmaceutical, nutraceutical, and medical markets. The company?s Energy segment provides metallic and non metallic gaskets; and various types of stud bolts, industrial fasteners, and specialty products for petroleum refining, petrochemical, oil field, and industrial markets. Its Aerospace and Defense segment offers aerospace fasteners and military munitions components to serve aircraft and weapons platforms in the aerospace and defense industries. The company?s Engineered Components segment provides natural gas engines and par ts, compressors, gas production equipment, and chemical pumps engineered for well sites for the oil and gas industry; and high-pressure and low-pressure cylinders for the transportation, storage, and dispensing of compressed gases. Its Cequent Asia Pacific and Cequent North America segments offer custom-engineered towing, trailering, and electrical products, including trailer couplers, winches, jacks, trailer brakes and brake control solutions, lighting accessories, and roof racks for recreational vehicle, agricultural/utility, marine, automotive, and commercial trailer markets; and functional vehicle accessories and cargo management solutions comprising vehicle hitches and receivers, sway controls, weight distribution and fifth-wheel hitches, hitch-mounted accessories, and other accessory components. The company sells its products through direct sales force, third‑party agents, distributors, licensees, and independent sales representatives. TriMas Corporation is based in Bloomfield Hills, Michigan.
Advisors' Opinion:- [By Luke Jacobi]
Shares of TriMas (NASDAQ: TRS) were down 10 percent to $26.59 after the company cut its full-year profit outlook. The company also announced its plans to buy Allfast Fastening Systems for around $360 million.
Top 10 Promising Stocks For 2015: Vocus Inc.(VOCS)
Vocus, Inc. provides cloud marketing software that enables businesses attract, engage, and retain customers in the United States, Europe, Asia, and Morocco. It offers a suite of software for social media marketing, search marketing, email marketing, and publicity. The company?s cloud marketing solutions include search marketing and news distribution solution that helps customers increase their online visibility and organic search engine rankings with press releases; and email marketing solution, which provides a method of keeping in touch with prospects and customers by using professional looking emails to send newsletters, special offers, and other useful content. Its cloud marketing solutions also comprise social media software solution that helps customers run social marketing campaigns, as well as monitor and analyze conversations across multiple social networks and other online Websites; and publicity solution, which offers media database, news monitoring, and analyt ics and publicity opportunities that help companies increase their media exposure, manage relationships with reporters, and monitor and analyze trends unfolding in the media. The company also provides professional services that consist of data migration, custom development, and training. Vocus, Inc. sells its products to the financial and insurance, technology, healthcare and pharmaceutical, and retail and consumer products industries, as well as government agencies, not-for-profit organizations, and educational institutions through its direct sales channels, indirect sales channels, and the Internet. Vocus, Inc. was founded in 1988 and is headquartered in Beltsville, Maryland.
Advisors' Opinion:- [By Alex Planes]
What: Shares of Vocus (NASDAQ: VOCS ) have plunged 15% today after the company's forward guidance failed to impress the Street.
So what: Vocus reported its earnings last evening, and both the $46.6 million top line and the $0.01 earnings per share result were better than Wall Street's consensus, which sought a $45.3 million revenue number and a $0.02 loss per share. However, third-quarter guidance of $46.5 million to $46.8 million on the top line is below the $47 million consensus, and a $0.03 to $0.04 EPS result is roughly in line with the $0.03 consensus. Additionally, the full fiscal year's guidance of $188 million to $189 million is roughly in line with the $188.2 million consensus.
Proto-col Slim-Fizz is a distinctive appetite suppressant that contains the ground-breaking fibre Glucomannan, which is an organic soluble fibre derived from high quality fresh Konjac.
ReplyDelete